#United States #Wilmington #Clinical Trials #AI Assistant #Trialogics

Trialogics Unveils AI Assistant 'Tria'

Trialogics, a known innovator in clinical trial technology, recently launched its groundbreaking AI-powered assistant named Tria. This innovative tool is designed to enhance the efficiency of clinical trial operations while ensuring a patient-centric approach.

In an age where clinical trials are becoming progressively intricate and costly, the introduction of Tria seems timely. Traditional methods often involve tedious manual processes and scattered data management systems, resulting in delays and inefficiencies. Tria aims to address these pressing challenges through advanced Natural Language Processing (NLP) technology, enabling users to quickly and securely access vital trial data.

Key Features of Tria

Tria allows users, including clinical research sites, Contract Research Organizations (CROs), and pharmaceutical sponsors, to interact in natural language, posing questions about protocol specifics, patient enrollment, clinical supply logistics, and real-time reporting. This intuitive communication model not only streamlines operations but also enhances user engagement. Here are some of Tria's standout benefits:

• - Human Oversight: Tria incorporates a human-in-the-loop strategy, ensuring clinical judgment remains at the forefront of decision-making.
• - Reduced Site Burden: By automating mundane protocol-related inquiries, site staff can devote more time to patient care rather than administrative tasks.
• - Efficiency Gains: The AI assistant simplifies study management, compliance monitoring, and data processing, yielding both time and cost savings.
• - Data Security: Built using Trialogics' robust permissions framework, Tria prioritizes compliance and data protection, assuring users of a secure environment.

CEO's Vision

Christopher Gropp, CEO of Trialogics, emphasized the company's commitment to enhancing customer interactions with their data securely and seamlessly. He suggests that the advent of Tria represents a significant step forward, propelling clinical trial capabilities into a new era powered by AI. Gropp also mentioned future plans for Tria to integrate with other systems to create a comprehensive knowledge base, ultimately improving decision-making and operational efficiency.

Flexibility and Integration

Tria can be fully integrated within the Trialogics clinical trial framework, supporting a variety of trial designs, including decentralized trials and patient-centric workflows. The system's interactions adhere strictly to Trialogics’ role-based permission and compliance guidelines, ensuring that data integrity and security are always maintained.

About Trialogics

Trialogics has established itself as a leader in providing innovative technology solutions for clinical trials. Their range of services includes eConsent, Interactive Response Technology (IRT), electronic Clinical Outcome Assessment (eCOA), and remote device management. The organization aims to simplify the complexities associated with clinical trials, improve data integrity, and expedite timelines for sponsors, CROs, and research sites globally.

For a deeper dive into Tria and to explore more about Trialogics’ clinical trial offerings, visit www.trialogics.com.